for Jun 28, 2022
🆕⚡⚡Review @jac_amr @TMcCarty2010@jobadd @DrPappasID
— Antibiotic Steward Bassam Ghanem🆔⚡ (@ABsteward) June 28, 2022
Clinical utility of antifungal susceptibility testing #IDTwitter #medtwitter #TwitteRx #MedEd https://t.co/kyWxc15KyE pic.twitter.com/I3VvFNkYWi
Super interesting⚡⚡
— Antibiotic Steward Bassam Ghanem🆔⚡ (@ABsteward) June 28, 2022
PIPPIN RCT, a multicentre, open-label, phase 3
[18F]FDG-PET-CT Vs. CT for persistent or recurrent neutropenic fever in high-risk pts
The 1ry endpoint :composite of starting,stopping, changing the spectrum of antimicrobial therapyhttps://t.co/JN1ig4euxO
New today in @ICHEJournal "Measuring empiric antibiotic spectrum—A journey through space and time"
— ICHE Journal (@ICHEJournal) June 28, 2022
▪️ Authors developed a visualization tool for antibiotic use
▪️ Visual patterns may provide opportunity for #AntimicrobialStewardship
📄: https://t.co/75zkPYuupM pic.twitter.com/9pysfdijD4
New article 🔥MRSA nasal swabs as an antimicrobial stewardship tool were associated with a reduced overall duration of Gram-negative therapy and Gram-negative antibiotic regimen cost. https://t.co/bPGL82YAnz Behavioral interventions are so interesting 🤯 pic.twitter.com/94H7wuxeip
— Tristan Timbrook (@TristanTimbrook) June 28, 2022
At @CGDev we've launched a working group on Antimicrobial procurement, and our first paper, a landscape analysis of current work to improve how antibiotics are purchased went out today. https://t.co/xaau4drATJ which I co wrote with @katklemperer @morgan_pincombe @JavierHGuzmanC
— Anthony McDonnell ❤️🇺🇦 (@apmcdonnell) June 28, 2022
🆕⚡@CMIJournal
— Antibiotic Steward Bassam Ghanem🆔⚡ (@ABsteward) June 28, 2022
Evaluation of the inoculum effect of new antibiotics against carbapenemase-producing Enterobacterales
The findings of CZA are intriguing #IDTwitter #medtwitter #TwitteRx #MedEd https://t.co/QOtIb7sv5I
Today's #shoutout to #womenInSTEM goes to @tinymuscles for her @CIDJournal paper on harnessing the power of health systems & networks for #AntimicrobialStewardship. #AMR #superbugshttps://t.co/4ThisOO5tW
— Steffanie Strathdee, PhD 🗡️ 🦠Superbug Slayer🗡️ (@chngin_the_wrld) June 28, 2022
🆕⚡Monte Carlo dosing simulations @jasonroberts_pk
— Antibiotic Steward Bassam Ghanem🆔⚡ (@ABsteward) June 28, 2022
A 2-g prophylactic cefazolin dose achieves appropriate unbound plasma & ISF concentrations n obese&morbidly obese bariatric patients
&FTA of >95% for all patients with BMIs ranging from 36 - 69 kg · m−2https://t.co/81ZmEOcgRy
In this study of >1.5 million hospitalizations & 45 million pt-days at-risk for antimicrobial therapy, shortening antimicrobial timing for sepsis was not associated with rising antimicrobial use or impaired antimicrobial stewardship. https://t.co/YRGecPqIZ4
— JAMA Internal Medicine (@JAMAInternalMed) June 28, 2022
*Red alert*
— APPG on Antibiotics (@APPGantibiotics) June 28, 2022
Read our report on what antibiotic residues in sewage & agricultural run-off mean for boosting potentially lethal superbugshttps://t.co/IoVnocjuO1@JulianSturdy @natalieben @WillHGaze @AimeeKMurray https://t.co/bj9Odaucav
Today we had the pleasure of launching our Citizen Jury report on #AMR
— Amanda Lamb FRSA (@waltzinglamb) June 28, 2022
Delivered earlier this year by @cndp_us we explored public opinions on the relationships between organisations involved in AMR & Antibiotic Stewardship https://t.co/2oLjYTWRyu pic.twitter.com/4vboIwnBf9
🆕⚡Case control study @JIDJournal
— Antibiotic Steward Bassam Ghanem🆔⚡ (@ABsteward) June 28, 2022
The presence of anti-Hepatitis E virus (HEV) antibodies was related to higher odds of CNS neurodegenerative disorders and neuropathological injury in older. people #IDTwitter #MedEd #TwitteRx https://t.co/b76SQCNztA pic.twitter.com/Is2puqSTgL
BREAKING💥💥
— Antibiotic Steward Bassam Ghanem🆔⚡ (@ABsteward) June 28, 2022
Positive results of ERADICATE RCT Ceftobiprole in comp.SAB
Ceftobiprole met pre-specified efficacy objective of overall mITT at 70d after randomization w/in pre-specified NI margin of 15% compared to daptomycin +/-aztreonam
H/t @GERMANESPARZA_ https://t.co/rrct9PfPpn
The National Institute of Allergy and Infectious Diseases has awarded #UBuffalo a $4 million grant to study what causes hypermutated strains of deadly antibiotic-resistant bacteria to develop, and how to prevent them. https://t.co/rJkwEje3O3
— President Satish K. Tripathi, University @ Buffalo (@UB_President) June 28, 2022
Qualitative analysis of factors influencing inpatient antibiotic prescribing decisions in VA among 49 clinicians and 15 hospitals. 31 factors identified⬇️ Anyone want to make a DAG? 🤓⤵️➡️⤴️https://t.co/A0FkxiaNpW pic.twitter.com/I6nw4GQMwG
— Tristan Timbrook (@TristanTimbrook) June 28, 2022
A reassuring study out of South Africa suggesting outcomes for BA4/5 similar to BA1 with protection with prior infection and boosted vaccinations.
— Zain Chagla (@zchagla) June 28, 2022
Caveats - younger and ++ natural immunity.
Very thankful for South African scientists for their workhttps://t.co/yh5juIig1N
Study finds that highly antibiotic-resistant #MRSA has emerged in livestock in past 50 yrs, probably due to widespread antibiotic use in pig farming.
— MicrobesInfect (@MicrobesInfect) June 28, 2022
The strain (#CC398) has become the dominant MRSA in Europe & is a growing cause of human MRSA infectionshttps://t.co/kufnVV4F6Z
#ICYMI: Valerie Leung and Julie Hui-Chih Wu won @CPJ_RPC's Best Paper of 2021 for their research on community #pharmacist prescribing of antimicrobials!
— CPhA/APhC (@CPhAAPhC) June 28, 2022
📖 Read the article & learn more about the award: https://t.co/dH83RaERCg#AMR #antimicrobialstewardship pic.twitter.com/OvO70Uei0K
🆕⚡⚡Large cohort #AAC
— Antibiotic Steward Bassam Ghanem🆔⚡ (@ABsteward) June 28, 2022
Risk Factors of Recurrent Infection in Patients with SAB, a Competing Risk Analysis
Of 1,725 (50% MRSA) ONLY 85 (5.0%) experienced recurrence
RFs for recurrence : vasc graft, RIF R, nasal. MRSA carriage#IDTwitter #twitterx #MedEd https://t.co/BUucEjV9D1
Why is your patient with cellulitis on antibiotics not improving? Considerations for progression of disease while on antimicrobial therapy (4W’S) @swinndong #BJHM #FOAMed #MedEd #Medtwitter #IDtwitter #IDMedEd #stewardship #Tipsfornewdocs pic.twitter.com/4HLKjaoAAI
— Brown Journal of Hospital Medicine (@BrownJHM) June 28, 2022
What would a world without antibiotics be like? Learn about the grave threat posed by #antibioticresistance from this eye-opening short video by @BBCideas 👉 https://t.co/ENYg9ibxcc#AMR #antimicrobialresistance #infectiousdiseases pic.twitter.com/qZNahtuQdh
— Ecraid (@Ecraid) June 28, 2022
🦠 Antimicrobial resistance is a massive threat to individual health, societal health and to our ability to safely deliver healthcare, according to Professor Alison Holmes who appeared in front of the @CommonsSTC last week.
— Imperial College (@imperialcollege) June 28, 2022
⬇️https://t.co/801BOqENML
Data visualisation 👉 inform clinical practice
— Gabriele Pollara (@gpollara) June 28, 2022
Antibiotic spectrum in a hospital over day & time of week 👇
Some interesting patterns & for sure can be revised, but most of all, I like the approach.
👍@rebsmoe @ICHEJournal #antimicrobialstewardship #AMR https://t.co/dUDzaIkqrl pic.twitter.com/CE5HVQ0DB9
“An increasing number of bacteria are resistant to #antibiotics, potentially placing us on course for another pandemic that, unlike the current one we live in, is preventable if we prioritize rebuilding the antibiotics pipeline." —@MaryDwight in @thehill https://t.co/oZKG598WiD
— Save Antibiotics (@saveantibiotics) June 28, 2022
Super interesting⚡⚡
— Antibiotic Steward Bassam Ghanem🆔⚡ (@ABsteward) June 28, 2022
Using a visualization tool for measuring empiric antibiotic spectrum
A 🆕⚡ @rebsmoe Al
found Empiric antibiotic prescribing patterns differed across space & time; broader antibiotic choices occurred in the ICUs, on nights & weekends https://t.co/Vb1DSEEjPQ
Great read! I was so reactogenic to all the 3 Pfizer covid vaccines. I have received!
— Antibiotic Steward Bassam Ghanem🆔⚡ (@ABsteward) June 28, 2022
Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection #IDTwitter https://t.co/yIBq7d5G4p
New Analysis Shows Micronutrient Deficiency On Admission To Hospital For COVID-19 Related To High Risk Of ICU Admission & Death https://t.co/kUmKmf8qJ3 #coronavirus #infectiousdiseases #micronutrients #vitamindeficiency
— Dr. Rath Foundation (@rathfoundation) June 28, 2022
New Analysis Shows Pfizer & Moderna COVID-19 #Vaccines More Likely To Cause Serious Adverse Events Than Prevent Hospitalization https://t.co/STToHjmf0d #coronavirus #infectiousdiseases
— Dr. Rath Foundation (@rathfoundation) June 28, 2022
Great article. The educational game being played is 'AMS (Antimicrobial Stewardship) Game' and its website is here: https://t.co/mXKOWIukvj
— Serious Games & Simulations (@FocusGames) June 28, 2022
A #Chinese study detailed in The #Lancet #InfectiousDiseases journal showed neutralising #antibodies against some #Omicron sub-variants were largely undetectable after 2 doses of a #Sinopharm #Covid #vaccine with a booster shot only partly restoring them.https://t.co/psPArqXVF9
— Himalaya Oxford Visionary Farm 英国牛津梦想农场 (@OXVisionaryFarm) June 28, 2022
Looking for more information on #AMS and how it can be used in your practice? 🦠
— BSAC (@BSACandJAC) June 28, 2022
Join the free 6-week #AbxSteward course to learn more about #AMR and stewardship while gaining 18 #CPD points along the way!
Sign up in one of five languages today🌎 https://t.co/L3QgCybXLZ pic.twitter.com/C7vvtwyWTJ
Important article⚡⚡
— Antibiotic Steward Bassam Ghanem🆔⚡ (@ABsteward) June 28, 2022
Robust neutralisation evasion by BA.4 & BA.5 more adept than BA.1 or BA.2 to spread in populations that are vacc or recovering from omicron, or both
Bebtelovimab neutralised all. Omicron subvariants tested w similarly high efficacyhttps://t.co/unroJgb9Pq
Prof Alison Holmes warned of the "massive" threat of antimicrobial resistance to health at last week's Science and Technology Committee inquiry 💊 #AMRhttps://t.co/68IMf8SL15
— Imperial Department of Infectious Disease (@ImperialInfect) June 28, 2022
Analysis of 500 clinical isolates of the human fungal pathogen, Candida glabrata, revealed dramatic variation in the ploidy state of a subset of isolates, thus challenging the long-held belief that C. glabrata is a haploid organism. Read more in #mSphere: https://t.co/y9pJmqswAm pic.twitter.com/wYlbuohiPc
— ASM (@ASMicrobiology) June 28, 2022
'Intensive farming behind antibiotic-resistant MRSA, say researchers' #StopSuperbugs #AMRSOS https://t.co/aPdsxXY0uL
— Stop Superbugs (@TheUrgentNeed) June 28, 2022
A procuratorate in Beijing has approved the arrest of four suspects from Jinzhun Medical Testing Laboratories on suspicion of hindering the prevention and control of infectious diseases as the lab was found violating rules on coronavirus testing. https://t.co/Rt0UD4mKoY
— Global Times (@globaltimesnews) June 28, 2022
It is a real privilege to be at VIDO (@VIDOInterVac). Today, we complete another step towards protecting the world from emerging infectious diseases. #ScienceOn #LZCI @usask
— Dr. Arinjay Banerjee (@sci_questions) June 28, 2022
Sask. vaccine manufacturing facility the first of its kind in Canada. @CBCNews https://t.co/B1lQlb8TrK
Excellent questions answered in this fantastic feature @bmj_latest How long does SARS-CoV-2 stay in the body?
— Antibiotic Steward Bassam Ghanem🆔⚡ (@ABsteward) June 28, 2022
Where does the virus persist?
Does the length of time the virus stays in the body ⬆️ risk of long covid?
Does SARS-COV-2 differ from other viruseshttps://t.co/JrsoX6XDyx
We're pleased to feature in a Uganda news article titled "Enhancing #AntimicrobialStewardship capacity at @MakerereCHS through the #CwPAMS Health Partnership model
— Commonwealth Pharmacists Association (@CW_Pharmacists) June 28, 2022
with Buckinghamshire Healthcare NHS Trust"
Congratulations to our partnerships for making an impact!#CPApharm pic.twitter.com/5aPEcHVNKd
A professor of infectious diseases and immunology is questioning #Quebec’s COVID-19 #pandemic management with an analysis of provincial data, saying risks were overstated and measures uncalled for.https://t.co/ulgxrHGWqj
— Epoch Times Canada (@EpochTimesCan) June 28, 2022
As monkeypox continues to spread, 2 kids reported infected in Europe. Most kids do well; case series small but risk of poor outcome seems higher
— Infectious Diseases (@InfectiousDz) June 28, 2022
Neonate: 1 of 5 deaths in 40 pts in Nigeriahttps://t.co/xnMVWtEnKE
2 ICU stays among 24 kids in US 2003https://t.co/6jr092Rdf2
Worldwide, 49% of COVID-19 survivors reported persistent symptoms 4 months after diagnosis, estimates a meta-analysis of 31 studies published late last week in The Journal of Infectious Diseaseshttps://t.co/ang4iP4wT8
— pj (@pjhn22) June 28, 2022
📢We are proud to announce that #Antibiotics has been ranked with an improved Impact Factor for 5.222; ranking 68/279 (Q1) in "#Pharmacology & Pharmacy"; 39/94 (Q2) in "#Infectious Diseases".
— Antibiotics MDPI (@antibioticsmdpi) June 28, 2022
🎉Thank you all for your contribution and continued support.
👉https://t.co/1FSAQzmRCJ pic.twitter.com/kznjhetHeS
Infectious diseases. Trivia. On July 5th, these two worlds will collide! 💥
— Firstline (@firstlineorg) June 28, 2022
Get ready to test your knowledge and earn daily points with #MicrobialPursuit!
🔗https://t.co/O2Nvc1aeTg#MedEd #IDTwitter #MedTwitter pic.twitter.com/YYn5wS2NR9
Racial and ethnic disparities in coronavirus disease 2019... : @AIDS_Journal https://t.co/3BLfLTFWvP @Drbenderignacio "the presence of structural racial inequities above and beyond medical comorbidities increased the risk of COVID-19 among PWH."
— Carlos del Rio (@CarlosdelRio7) June 28, 2022
Tracking disease from outer space! Find out how #PHAC scientists are using satellites to study infectious diseases. 🌎https://t.co/DjUjcddOEg pic.twitter.com/AJhTUcJP1c
— Health Canada and PHAC (@GovCanHealth) June 28, 2022
“There is a major gap in the discovery of #antibacterial treatments, and more so in the discovery of innovative treatments,” @WHO’s @HananBalkhy says. https://t.co/KaRz65RrxX
— Save Antibiotics (@saveantibiotics) June 28, 2022
How do aged-care staff feel about antimicrobial stewardship? A systematic review of staff attitudes in long-term residential aged-care https://t.co/C48AhG3lHV
— Antimicrobial Resistance and Infection Control (@ARICJournal) June 28, 2022
#WorldMicrobiomeDay
— ReAct - Action on Antibiotic Resistance (@reactgroup) June 28, 2022
Life on Earth is arranged in ecosystems - all species are dependent on each other.
Humans harbor an ecosystem of microbes called the human microbiome.
What are the effects of #antibiotics on the microbiome?
More in ReAct factsheet👇🏾https://t.co/BYigW26j8Q pic.twitter.com/TZXHYP73d7
MAPPINGS, a tool for network analysis of large phospho-signalling datasets:
— MicrobesInfect (@MicrobesInfect) June 28, 2022
Application to host erythrocyte response to #Plasmodium infectionhttps://t.co/8iOjNr8n1X #openaccess #malaria pic.twitter.com/6877zeYXKI
New in #MRAJournal! Researchers introduce a data set of near-full-length 16S rRNA genes from samples designed to capture known geographic & seasonal variations in municipal wastewater microbial communities. https://t.co/uVOtOVYSx6 pic.twitter.com/bZhgDXnYCm
— ASM (@ASMicrobiology) June 28, 2022
“We should be anticipating problems and doing something about them before they become enormous global crises,” @wellcometrust’s Dr. Anna Barnard says of the need to address #antibioticresistance now – before it’s too late. https://t.co/5McPCQW4LR https://t.co/LUR4Gt5aUF
— Save Antibiotics (@saveantibiotics) June 28, 2022
PRO/AMR> Antimicrobial stewardship (59): LMICs, cefiderocol access for AMR infections https://t.co/m0eOJgwG4X
— ProMED-mail (@ProMED_mail) June 28, 2022
An infectious diseases expert noted that COVID-19 booster shots are much needed as reinfection may lead to higher health risk and hospitalization. https://t.co/iyPUJqu48h
— CNN Philippines (@cnnphilippines) June 28, 2022
CDC opens #monkeypox emergency ops center as Europe begins vaccinations
— CIDRAP (@CIDRAP) June 28, 2022
Also, "Many individuals are presenting with atypical symptoms," the WHO sayshttps://t.co/fL3MilPXOc pic.twitter.com/Oq1qWB8fVI
Cool study from 🇦🇺:
— Andrew Morris (@ASPphysician) June 28, 2022
[18F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3 RCT. https://t.co/pYvrpWN0Xq
Key research on #COVID19 #AMR #AntibioticStewardship
— CIDRAP (@CIDRAP) June 28, 2022
NEWS SCAN: COVID-19 infectious period; Antibiotic-resistant UTIshttps://t.co/hLCAhaiUNI
Our article entitled "The microbiome of cryospheric ecosystems" is part of Nature Communication's Editors' highlights in the "Microbiology and infectious diseases" focus 🦠❄️🔬: https://t.co/FpaJEfSm5n @NatureComms @RIVER_epfl @susheelbusi
— Massimo Bourquin (@MassB23) June 28, 2022
Trial of potential universal #fluvaccine opens at @NIH
— MicrobesInfect (@MicrobesInfect) June 28, 2022
A Phase 1 clinical trial of a novel #influenza vaccine has begun with healthy volunteers. The trial will test safety of a candidate vaccine (BPL-1357) & its ability to prompt immune responses.https://t.co/78t7eE1bl5 #flu
Check out our new publication first-authored by @karim_marwah highlighting the role of Numb-associated kinases in SARS-CoV-2 #infection and as #antiviral #drug #targets! https://t.co/Y61PzggAEJ#SARSCoV2 #COVID19 #virology #kinases #stanford #drugdiscovery #infectiousdiseases
— Einav Lab (@EinavLab) June 28, 2022
FDA advisers call for #Omicron update for #COVID19 boosters
— CIDRAP (@CIDRAP) June 28, 2022
VRBPAC experts approved the booster recommendation by a 17-to-2 votehttps://t.co/81qYSU2ZjX pic.twitter.com/hbeDOXcsqt
Intermittent fasting changes gut bacteria activity of mice & increases their ability to recover from nerve damage.
— MicrobesInfect (@MicrobesInfect) June 28, 2022
Study shows that gut bacteria increase production of the metabolite 3-Indolepropionic acid (IPA), which is required for regenerating axonshttps://t.co/9pdK8X7P8n
Are you looking to study MSc Infectious Diseases with @LSHTM? Join Programme Directors, Dr Patricia Gorak-Stolinska and Anita Skinner, at our Postgraduate Health Day webinar to find out more: https://t.co/DqNeqOe39H #UoLWebinars pic.twitter.com/1mlqFDQUza
— University of London (@LondonU) June 28, 2022
Great to see this response to our article by @edcpt colleagues highlighting a positive example of equitable research partnerships https://t.co/TKcK23ZXqu
— Esmita Charani (@e_charani) June 28, 2022
⛓ to our 📑 https://t.co/uwi2GumDK9@SouthAfricanASP @muneera_rasheed @OneHealthTrust @seyeabimbola @paimadhu @SojiAdeyi
Monkeypox is in the news. An infectious disease specialist helps clarify what you need to know about monkeypox symptoms and how to avoid the illness.https://t.co/qs2YayuNr7
— Johns Hopkins Medicine (@HopkinsMedicine) June 28, 2022
Our pipeline is focused on harnessing our CpG 1018 adjuvant as an advanced vaccine adjuvant to discover, develop, and commercialize vaccines to prevent infectious diseases, including for #COVID19. Learn more about our future products here: https://t.co/tqLXC5FRtR. pic.twitter.com/2Ee0MeAAXz
— Dynavax (@DynavaxCorp) June 28, 2022
Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study | Clinical Infectious Diseases | Oxford Academic
— Max Powers (@MaxPowerRocks) June 28, 2022
How long is COVID-19 infectious? The article details this. Read on https://t.co/KLdKKf3dxv
🔮 Happy to share in important article about the #Telepharmacy that show successful outcomes during the #COVID19 pandemic
— Rasha Abdelsalam Elshenawy💙 (@salam_rasha) June 28, 2022
💊The #pharmacist involving in telepharmacy models ensures high #quality care, such as #medication reviews.
Read more from here:https://t.co/BabFC0H49p pic.twitter.com/N41cXFXrmc
BA.4/BA.5 vs previous waves in South Africa⚡
— Antibiotic Steward Bassam Ghanem🆔⚡ (@ABsteward) June 28, 2022
Disease severity was similar amongst diagnosed COVID-19 cases in BA.4/BA.5 & BA.1 periods in the context of growing immunity against SARS-CoV-2 due to prior infection & vaccination,both were strongly protective https://t.co/RZ1QwOVJF0
🆕⚡Retrospective cohort Late-onset opportunistic infections(LOI) while receiving anti-retroviral therapy in Latin America: burden & risk
— Antibiotic Steward Bassam Ghanem🆔⚡ (@ABsteward) June 28, 2022
LOI occurred in nearly 1 in 10
A protease inhibitor based regimen (HR 1.25) was associated with a higher risk of LOI🤔 https://t.co/8rXCr2LCsh
Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review https://t.co/P6xI97TsyW The likelihood of having long COVID syndrome was significantly greater among females (OR = 1.22; 95% CI: 1.13–1.32).
— Carlos del Rio (@CarlosdelRio7) June 28, 2022
#Israeli scientists are researching a method to genetically modify #whitebloodcell in order to create the first injectable for #HIV sufferers. Share your viewpoints in the 6th International Conference on #Emerging #Infectious #Diseases
— Shelly Claycomb (@shelly_claycomb) June 28, 2022
➡️https://t.co/Buib9sQfdi#vaccination pic.twitter.com/F04aXYrcpg
Our June 28 NFID Webinar on optimal vaccination of immunocompromised patients is now available ICYMI – National Foundation for Infectious Diseases https://t.co/pdKqNuWG1F
— Camille Nelson Kotton (@KottonNelson) June 28, 2022
Thousands of new viruses are expected to spread among animal species by 2070 if the world warms by a few degrees,
— The Doomsday News 🗞 (@thedoomsdaynews) June 28, 2022
via @HuffPost https://t.co/wmXsmIV4e8
Wide variation in COVID prevention at “top” US hospitals:
— Tim Lahey, MD, MMSc (@TimLaheyMD) June 28, 2022
- 78% universal procedure masks, 22% N95s
- 70% required eye protection
- 96% used N95s for COVID-19 care, 4% only for AGP
- 91% tested asymptomatic admissions
- 22% tested unvaxed employees weekly https://t.co/v6zxJSoquf
🔈Listen to Professor Nigel McMillan, MHIQ's director of Infectious Diseases and Immunology, interviewed by ABC radio about the fourth COVID-19 vaccine dose that is highly likely to be rolled out as cases are on the rise again. 📻💉😷
— MenziesHealth (@MenziesHealth) June 28, 2022
Starts from 1hr.50 👉 https://t.co/k8h52nI2ZB pic.twitter.com/KQViMD7jhL
As Monkeypox Spreads, U.S. Plans a Vaccination Campaign @apoorva_nyc via @NYTimes https://t.co/Bj5voZRhNw
— Carlos del Rio (@CarlosdelRio7) June 28, 2022
"Recent outbreaks of measles and mumps in Britain reveal how many children have not had their routine childhood jabs, and how complacency over vaccination has taken hold as memory of diseases such as whooping cough and tetanus fades."https://t.co/qeulNXs4Zs
— John Grumble (@DrGrumble) June 28, 2022
Development of a Centralized Antimicrobial Stewardship Program Across a Diverse Health System and Early Antimicrobial Usage Trends https://t.co/sQL0cH5e3z
— PARN (@PARNetwork) June 28, 2022
Indigenous mRNA vaccines could change the fight against COVID as well as many other infectious diseases like malaria, tuberculosis, and dengue. https://t.co/ygGwQbDzvs
— Quint Fit (@QuintFit) June 28, 2022
The last time scientists discovered a novel class of #antibiotics that would eventually make it to market was in 1984.
— Save Antibiotics (@saveantibiotics) June 28, 2022
Hear from Richard Baltz, one of the researchers who helped develop the drug, daptomycin. @pewhealth https://t.co/gb2V3qFyzJ
There’s only 30 more minutes until we go LIVE! Join us at 7:30 for the session, ‘Antimicrobial Resistance and Stewardship: What you need to know’. To join, simply visit our FB page where the video will be pinned to the top: https://t.co/lrgbsivaV6 @essity pic.twitter.com/B7zqVfvZbS
— Wound Care Today (@WCTreport) June 28, 2022
We'll be going LIVE on Facebook at 7:30PM, where we will be discussing ‘Antimicrobial Resistance and Stewardship: What you need to know’. Click ‘Going’, where you will receive instructions on how to join, as well as be reminded when we’re live: https://t.co/7QDCy8Sudk @essity pic.twitter.com/YtCBVTwjq9
— Wound Care Today (@WCTreport) June 28, 2022
🤩🤩 Fantastic conversation on mechanisms of resistance and treatment strategies for this increasingly popular pathogen 🦠. Love the balance of bench and bedside perspectives!! Another reason to be skeptical of levofloxacin 🤨 #IDTwitter #MedEd https://t.co/F01HdftrV7
— M_LaguioVila (@M_LaguioVila) June 28, 2022
Worldwide, 49% of COVID-19 survivors reported persistent symptoms 4 months after diagnosis, estimates a meta-analysis of 31 studies published late last week in The Journal of Infectious Diseaseshttps://t.co/ang4iP4wT8
— pj (@pjhn22) June 28, 2022
Another BIG JUMP.
— Donna Young 📰 🗞️ (@DonnaYoungDC) June 28, 2022
As of June 28, #CDC reports total confirmed U.S. #monkeypox/orthopoxvirus cases at 306.https://t.co/TLnOWS3O0N
27 states & D.C. reporting cases
Nebraska latest to reporthttps://t.co/RgiufRbkw8 #publichealth #infectiousdiseases
Children ages 6 months through 4 years are eligible to receive the COVID-19 vaccine. Pediatric Infectious Diseases Director, Dr. Angela Myers is talking with @GoodDayKansas about the process and how parents can help comfort kids during the vaccine.https://t.co/hFWRvWVo2e
— Children's Mercy (@ChildrensMercy) June 28, 2022
The need for laboratory professionals is expected to grow by 11% b/w 2020-2030. In full support of clinical microbiologists, we aim to be proactive in addressing critical staffing shortages. See ASM's 2021 Clinical Microbiology Workforce Survey results: https://t.co/YiFvWq8LjE
— ASM (@ASMicrobiology) June 28, 2022
The viruses and bacteria that cause illness and death still exist and can be passed on to those who are not protected by #vaccines.
— NFID (@NFIDvaccines) June 28, 2022
RT to share 9 more reasons to #GetVaccinated: https://t.co/6WuVbMzUMT pic.twitter.com/OYtD7b69wt
What a fantastic opportunity - combined Infectious Diseases fellowship & @CDCgov's Epidemic Intelligence Service. One application, four years of training. Hoping pediatrics will be added in the future.
— Dr. Alicia (@aliciad3) June 28, 2022
cc @IDSAInfohttps://t.co/dSzWAl9Gop
“The ERADICATE study provides strong support for the efficacy and safety of ceftobiprole in complicated SAB” 🔥🔥 #IDtwitter https://t.co/YBRmFnLiGP
— ACCP INFD PRN (@accpinfdprn) June 28, 2022
🆕⚡@TheLancetInfDis
— Antibiotic Steward Bassam Ghanem🆔⚡ (@ABsteward) June 28, 2022
Does it matter who is spreading monkeypox? #IDtwitter https://t.co/27RQEo3Crx
Happening now!
— Daktari Online (@DaktariOnline) June 28, 2022
Join us on https://t.co/fnfyp2BXlI for a stimulating discussion on Antimicrobial Stewardship. pic.twitter.com/nfYQQGPaHJ
NYC cases, without more testing, cannot rise much faster than this.
— Infectious Diseases (@InfectiousDz) June 28, 2022
Without more monkeypox testing many may be diagnosed with syphilis, warts or herpes in the meantime or may be stymied by lack of testing
CDC still reports 37 cases in all of NY statehttps://t.co/EPQWtjrci2 https://t.co/w9FJm4fO4C
epidemics of several different infectious diseases (meningococcal, TB, HIV, Herpetic diseases, etc.) as well as that of 2 major pandemics (even if not yet officially declared as pandemics), i.e., Monkeypox and Avian Flu are related to the mass vax program.https://t.co/IrtLbj9T7u
— Timothy Gravert (@TWILLYG2) June 28, 2022
🆕⚡@CIDJournal
— Antibiotic Steward Bassam Ghanem🆔⚡ (@ABsteward) June 28, 2022
Early treatment of high-risk hospitalized COVID-19 patients with a combination of interferon beta-1b and remdesivir: a phase 2 open-label randomized controlled trialhttps://t.co/mFdIFG6QON
Don't miss this interesting Commentary about #DiagnosticStewardship in #InfectiousDiseases: https://t.co/dcV1xqyEAj
— Future Microbiology (@fsgfmb) June 28, 2022
Take #Pride by sharing facts about #PrEP, #PEP, and #HIV treatment. Together can we help #StopHIVStigma and increase HIV awareness in our communities. Learn how: https://t.co/af8vKfTITX#StopHIVTogether #Pride @IDSAInfo @HIVMA @CDCgov pic.twitter.com/qdF2nJH7hs
— SIDP (@SIDPharm) June 28, 2022
Created by Cameron Forbes. Last updated June 29, 2022 at 05:16 EST.